| LTT | Long-term cisplatin treated |
| LTTs | Long-term cisplatin treated cell lines |
| STT | Short-term cisplatin treated |
| UC | Urothelial carcinoma |
| UCCs | Urothelial carcinoma cell lines |
| SDHA | Succinate dehydrogenase complex |
| NRF2/NFEL2L | Nuclear factor (erythroid-derived 2)-like 2 |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| p62/SQSTM1 | Sequestosome-1 |
| ROS | Reactive oxygen species |
| GSH | Glutathione |
| GSR | Glutathione reductase |
| NQO1 | NAD(P)H quinone dehydrogenase 1 |
| HMOX1 | Heme oxygenase 1 |
| GPX1/2 | Glutathione peroxidase 1/2 |
| GST | Glutathione S-transferase |
| GCLC | Glutamate–cystein ligase catalytic subunit |
| GCLM | Glutamate–cystein ligase modifier subunit |
| SLC3A2 | 4F2 cell-surface antigen heavy chain |
| SLC7A11 | Cystine/glutamate transporter |
| YAP1 | Yes associated protein 1 |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| SCC | Squamous cell carcinoma |
| CHUK/IKKα | IκB kinase |